跳至主要内容
临床试验/NL-OMON50538
NL-OMON50538招募中不适用

Early TUbectomy with delayed oophorectomy to improve quality of life as alternative for risk reducing salpingo-oophorectomy in BRCA1/2 gene mutation carriers - TUBA study

Gynaecologie en Verloskunde0 个研究点目标入组 510 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
510

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Premenopausal women with a documented BRCA1 and/or BRCA2 germline mutation
  • - Age 25-40 years for BRCA1 mutation carriers, 25-45 years for BRCA2
  • - Childbearing completed
  • - Presence of at least one fallopian tube
  • - Participants may have a personal history of non-ovarian malignancy

排除标准

  • - Postmenopausal status (natural menopause or due to (cancer) treatment)
  • - Wish for second stage RRO within two years after RRS (if clear at enrollment)
  • - Legally incapable
  • - Prior bilateral salpingectomy
  • - A personal history of ovarian, fallopian tube or peritoneal cancer
  • - Evidence of malignant disease at enrollment
  • - Current treatment for malignant disease
  • - Inability to read or speak Dutch

研究者

发起方
Gynaecologie en Verloskunde

相似试验